SciELO - Scientific Electronic Library Online

 
vol.5 issue1Determination of growth status, levels of insulin growth factor type 1 (IGF-1) and vitamin D in patients with juvenile idiopathic arthritis treated at the IssemYm maternal and Child Hospital in Toluca de Lerdo, MexicoAlveolar hemorrhage as a form of systemic lupus erythematosus debut author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista Paraguaya de Reumatología

On-line version ISSN 2413-4341

Abstract

OJEDA, Aldo et al. Giant cell arteritis. Rev. parag. reumatol. [online]. 2019, vol.5, n.1, pp.20-26. ISSN 2413-4341.  https://doi.org/10.18004/rpr/2019.05.01.20-26.

The Giant Cell Arteritis is considered one of the most prevalent autoimmune vasculitis syndromes, which affects arteries of medium and large caliber, being the most feared complication, anterior ischemic optic neuropathy that can evolve to an irreversible loss of vision. The symptoms are caused by local ischemia due to endovascular damage accompanied by systemic damage mediated by cytokines. In recent years, doppler ultrasound, Magnetic Resonance Imaging (MRI) and PET scans have become important in the search for tools that can confirm or exclude the diagnosis of GCA. However, the Temporal Artery Biopsy (BAT) continues to be the gold standard test for the diagnosis of this disease.

Keywords : Giant Cell Arteritis; diagnosis; treatment.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )